DHR
Danaher CorporationNYSEHealthcare$191.12+0.17%OpenMarket Cap: $135.15B
As of 2026-04-06
Valuation
P/E (TTM)
37.40
PEG
—
P/B
2.57
P/S
5.50
EV/EBITDA
21.45
DCF Value
$197.17
FCF Yield
3.9%
Div Yield
0.7%
Margins & Returns
Gross Margin
60.9%
Operating Margin
20.9%
Net Margin
14.7%
ROE
7.0%
ROA
16.1%
ROIC
5.7%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $6.84B | 58.0% | $1.50B | $1.20B | $1.68 | $0.32 |
| FY 2025 | $24.57B | 60.9% | $5.14B | $3.61B | $5.04 | $1.55 |
| Q3 2025 | $6.05B | 58.2% | $1.15B | $908.0M | $1.27 | $0.64 |
| Q2 2025 | $5.94B | 66.6% | $1.19B | $555.0M | $0.77 | $0.64 |
| Q1 2025 | $5.74B | 61.4% | $1.29B | $954.0M | $1.32 | $0.59 |
| Q4 2024 | $6.54B | 59.5% | $1.75B | $1.09B | $1.49 | $0.54 |
| FY 2024 | $23.88B | 59.5% | $5.18B | $3.90B | $5.29 | $1.32 |
| Q3 2024 | $5.80B | 58.7% | $958.0M | $818.0M | $1.12 | $0.54 |
| Q2 2024 | $5.74B | 59.7% | $1.17B | $907.0M | $1.22 | $0.54 |
| Q1 2024 | $5.80B | 60.2% | $1.31B | $1.09B | $1.45 | $0.51 |
| Q4 2023 | $6.41B | 59.0% | $1.41B | $1.08B | $1.45 | $0.51 |
| FY 2023 | $23.89B | 58.7% | $5.28B | $4.76B | $6.38 | $1.30 |